One of the triazole antifungal agents that inhibits cytochrome P-450-dependent enzymes resulting in impairment of ergosterol synthesis. It has been used against histoplasmosis, blastomycosis, cryptococcal meningitis & aspergillosis.
For the treatment of the following fungal infections in immunocompromised and non-immunocompromised patients: pulmonary and extrapulmonary blastomycosis, histoplasmosis, aspergillosis, and onychomycosis.
Syneos Health Clinic Inc., Québec, Quebec, Canada
Chest Clinic, Dept. of Pulmonary Medicine, Chandigarh, India
Research Site, Ruddington, United Kingdom
Local Institution - 0001, Tempe, Arizona, United States
Beijing GoBroad Hospital, Beijing, Beijing, China
Altasciences Clinical Kansas, Overland Park, Kansas, United States
Fortrea Clinical Research Unit Inc., Dallas, Texas, United States
Shanghai Xuhui Central Hospital, Shanghai, Shanghai, China
The first hospital of Jilin University, Changchun, Jilin, China
Humanpharmakologisches Zentrum Biberach, Biberach, Germany
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.